Skip to main content
. 2020 Apr 21;10:549. doi: 10.3389/fonc.2020.00549

Figure 7.

Figure 7

Analyses of peripheral and intratumoral CD8+ T-cell PD1 expression following bintrafusp alfa administration. (A) Association between PD1 expression in splenic (A) or intratumoral (B) CD8+ T cells vs. tumor weight at day 21 post-initiation of bintrafusp alfa treatment in bintrafusp alfa-treated PBMC humanized mice. (C) Splenic or (D) tumor CD8+ PD1 expression in animals responding to bintrafusp alfa (tumor weight <263 mg) vs. those not responding (tumor weight >263 mg) in HTB-1 humanized mice (***p < 0.0001, student's t-test).